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Introduction

Since the second half of the twentieth century, non-human animals (hereinafter referred to as animals) have been widely used as models for researching
human disorders. Historically, this occurred for two main reasons: a) animals
are complex living systems; and b) it is considered less ethically-contentious
as well as easier, quicker, and cheaper to use animals than humans. Their benefit for biomedical advancement is assumed even though systematic evaluations, though uncommon, suggest otherwise. It is crucial to evaluate whether
animal-based biomedical research successfully benefits medical research—
even through indirect pathways—or if it is being used merely to justify further
animal-based research. In this chapter we demonstrate that there is a lack of
communication between animal-based research and clinical research. We discuss possible reasons for this and reflect on whether animal use in biomedical
research is, indeed, fulfilling its primary purpose.
Humans share a long evolutionary story with the rest of the animal kingdom, which explains common physiological and behavioral traits and adaptations. For example, basal ganglia, a set of subcortical nuclei involved in
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several motor functions, are present throughout vertebrate taxa and are largely
similar across species (Lee et al., 2015). Similarly, the rise of body temperature
as a response to infection is shared by humans and other mammals (Nesse and
Williams, 1996; Schaffner, 2006). Even poikilothermic (cold-blooded) animals,
such as lizards, tend to move to warmer places when they are ill, until their
body temperature is several degrees above normal (Nesse and Williams, 1996).
The relatively recent decoding of genomes had shown an impressive number
of genes shared between ourselves and taxonomically-distant species, such
as the frog (Hellsten et al., 2010). These similarities provided the basis for the
untested assumption that animals provide good research models for human
disorders.
However, we know that minimal biological changes can create significant
differences between species and individuals. For example, Darwin’s finches
comprise 14 closely-related species that vary dramatically in their feeding
habits, despite their biological proximity (Lack, 1947). Even amongst individuals of the same species, slight and almost undetectable differences can cause
very different adaptive responses. For example, human beings with sickle cell
trait may have increased protection from malaria but risk sudden death by
hypoxia, when visiting high altitudes or performing intense physical exertion
(Scheinin and Wetli, 2009; Webber et al., 2016), safe activities for most people.
Despite individual differences, it is obvious that human beings are the best
biomedical model for human disorders. However, clinical research is time
consuming and can have severe ethical constraints, which is one of the main
reasons why animals are widely used as models for human disorders. Recent
in vitro developments have allowed us to create cultures of human cells and
tissues (e.g., Petropolis et al., 2016; Wilson, Ahearne and Hopkinson, 2015) that
are considered superior to using animal samples for human-based research
(Clemedson et al., 1998; Huhtala et al., 2008; Petropolis et al., 2016). Nonetheless, among the scientific community, the main obstacle to the total replacement of animal use in biomedical research is not a desire to study cells, t issues,
or organs, but the desire to study entire, functioning bodily systems. This is
considered necessary when objectives include understanding a drug effect in
the whole organism or trying to understand the etiology and pathogenesis of
multifactorial disorders, such as mental disorders.
In silico techniques have been slowly addressing this issue, creating whole
body simulations (e.g., Viceconti, Clapworthy and Jan, 2008; Viceconti, Henney
and Morley-Fletcher, 2016). However, the availability of human data limits these
models. For example, if a new disease arises, models may fail to predict accurately the response of the human body to the new pathogen due to lack of data.
It should be noted that animal models also suffer from failure to predict human
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responses accurately. Despite the accepted potential of in silico techniques,
unvalidated animal models are still commonly believed to be the best available, so far, for studying the entire, functioning human body.
Throughout the years, various authors have asserted that animal research
has made only poor contributions to medical progress (e.g., Bailey, 2008;
Fadali, 1996; Greek and Greek, 2003; Shapiro, 1998), while others have asserted
the opposite (e.g., Illman, 2008; Shively and Clarkson, 2009; Perretta, 2009).
Such assertions are based upon historical analyses, investigations into the
development of various treatments, and critical reviews of animal model
use. Historical accounts are disputed. A classic example is the discovery of
the role of the pancreas in diabetes. Many claim that we owe this discovery
to experiments conducted by Minkowski and von Mering with dogs, in the
second half of the nineteenth century (cited in Bliss, 1982); whereas, others
argue that this medical breakthrough was achieved by Thomas Cawley, 100
years earlier, while performing autopsies on patients who died from diabetes
(cited in Fadali, 1996).
Investigations into the development of treatments are also controversial. A
good example is the development of the poliomyelitis vaccine. P
 oliomyelitis is
a viral disease that reached epidemic proportions in 1916. Some (e.g., Illman,
2008) state that it was the experiments performed on mice and monkeys that
allowed scientists to understand its pathogenesis and develop a vaccine. Furthermore, both poliomyelitis vaccines (Salk vaccine and Sabin vaccine) were
initially grown in monkey kidney tissue (Dowdle et al., 2003), reinforcing the
perception of the central role of animal experiments in the development of poliomyelitis treatment (Illman, 2008). However, others (e.g., Fadali, 1996) claim
that animal experiments delayed the vaccine’s development. Rhesus monkeys,
which provided a widely-used animal model for poliomyelitis, misled scientists
to believe that the virus was transmitted via the respiratory, rather than the
digestive route (Dowling, cited in Bailey, 2008), as earlier research on humans
had suggested (see Fadali, 1996, for a review). This mistake led to an erroneous clinical trial in 1937, in which exposed children suffered olfactory damage
(Parish, 1968). Also, the first poliomyelitis vaccines, grown on monkey kidney
cells, were responsible for the exposure of millions of American citizens to
simian virus 40, found in rare human cancers (Pennisi, 1997). When it comes
to non-human primates (nhps), these disputes are even more contentious,
because public opinion is less supportive of the use of nhps in research (European Commission, 2010). Furthermore, as technology evolves, better methods
become available, and the apparent historical necessity of animal experiments
becomes of less relevance. For example, vaccines that used to be developed using animal tissues—at times suboptimally due to poor efficiency (e.g., rubella
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vaccine developed through duck embryo cells and dog kidney cells) or zoonosis (e.g., the simian virus that reached humans through the first polio
vaccines)—are now being developed using human strains (Plotkin, 2017).
Recently more objective tools to assess the contribution of animal models
to biomedical progress have emerged. Such is the case of systematic reviews,
meta-analyses, and citation analyses. Systematic reviews are literature reviews
focused on a research question that aim to identify, appraise, and synthesize
all high-quality research evidence relevant to that question. They are generally
considered the best tool to produce evidence about the value of animal studies
(Pound et al., 2004), not only because they are designed to include all relevant
information, drastically reducing the potential for bias; but also because systematic reviews evaluate experimental designs through rigorous and objective peerreviewed protocols, such as the Animal Research: Reporting In Vivo Experiments
(arrive) guidelines that apply scientific method to the task of reviewing research evidence (Kilkenny et al., 2010). A meta-analysis can go even further
by incorporating a statistical representation of all the reviewed studies as well.
In the past decades, the number of systematic reviews shedding light on the
scientific value of animal studies has increased (e.g., Banwell, Sena and
Macleod, 2009; Corpet and Pierre, 2005; Lucas et al., 2002; Macleod et al., 2005;
Martić-Kehl et al., 2015; Perel et al., 2007). The systematic reviews have revealed:
a) poor transferability of animal outcomes to human clinical trials (e.g., Perel
et al., 2007); b) simultaneous occurrence of animal and clinical trials, rather
than sequentially, as expected given that the animal experiments should
be conducted first, to allow detection of possible toxicity (e.g., Lucas et al.,
2002); and, c) significant methodological and design flaws in a clear majority
of animal experiments (e.g., Martić-Kehl et al., 2015). Consequently, the use of
arrive or similar guidelines has become more common, which will hopefully
lead to better protocols and reduce redundant studies. As for the poor transferability of animal outcomes to human trials, it can be argued that this is either a
consequence of poor experimental design, and/or the fact that animal models
are not suitable models for human beings (Bailey and Taylor, 2016).
Another way to determine the value of animal studies is citation analysis,
which consists of determining the frequency with which a study is cited in subsequent papers. Several authors have conducted citation analyses on published
papers, reporting data from animals used as models for human disorders
(e.g., Carvalho et al., 2016; Knight, 2007; Long, Huang and Ho, 2014); results
show that these papers have received very few citations in human medical
papers. Again, it can be debated whether this occurs due to a false assumption that animal models are suitable models for human disorders or because
of methodological errors, or both.
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To try to address this issue, we performed a citation analysis on a small
sample of papers reporting data from animals used to model two complex
psychiatric disorders: attention deficit hyperactivity disorder (adhd) and major depressive disorder (mdd).
adhd is a chronic neurodevelopmental condition of multifactorial origin,
marked by persistent inattention; hyperactivity; and, occasionally, impulsivity (American Psychiatric Association, apa, 2013). It affects 2.2% of children
worldwide (Erskine et al., 2013); and it can be extremely disabling (apa, 2013).
mdd is a complex psychiatric mood disorder characterized by a persistent
feeling of sadness that seriously impairs normal day-to-day functioning and
may even lead to suicide (apa, 2013). Mental disorders are the leading cause
of years lived with disability worldwide, and 40.5% of this burden is caused by
mdd alone (World Health Organization, 2008).
In this study we categorized the citations obtained into animal versus human studies and determined whether human-based and animal-based papers
focused on the same disorder investigated by the animal study they were citing.
This form of analysis is valuable for shedding light on whether animal-based
research is being used to advance human healthcare, or whether it simply fuels
further animal-based research. If animal studies are contributing to human
healthcare advancements, then we would expect that:
1.
The citations made in human-based papers should be a substantial proportion of total citations.
2. The citations should be made mainly by studies focused on the same
disorder. Any substantial deviations would signal the possibility that animal-based research is not achieving its primary purpose.
2

Methods

We conducted a citation analysis as defined by Garfield and Merton (1979).
Briefly, in a citation analysis, one defines a number of target papers and conducts a search of all papers that cite these target papers. The information
obtained can include the total number of citations and patterns of citation.
We used a total of 50 target papers: 25 non-human animal studies on adhd,
and 25 non-human animal studies on mdd.
The adhd papers were selected from the citation analysis database created in the study by Carvalho et al. (2016). We included all papers reporting
data collected with primate models (7 papers) and randomly selected 18 papers from the remaining papers, using the free online tool, Research Randomizer (www.randomizer.org). The 25 studies were examined to determine the
proportion of citations each paper received in human-based papers focused
Constança Carvalho, Daniel Alves, Andrew Knight and Luis Vicente - 9789004391192
Downloaded from Brill.com07/10/2019 02:57:05PM
via free access

Is Animal-based Biomedical Research

381

on adhd, in human-based papers focused on other subjects, in animalbased papers focused on adhd, and in animal-based papers focused on other
subjects.
The mdd papers were obtained using PubMed to locate original articles
using animal models to investigate major depressive disorder (similar to the
protocol used in Carvalho et al., 2016). We searched PubMed using the following Medical Subject Heading (MeSH) search terms:
“Major Depressive Disorder” AND (title/abstract): “animal” OR “rat” OR
“mice” OR “mouse” OR “Rattus” OR “Mus” OR “pig” OR “Cavia” OR “Sus”
OR “rabbit” OR “Leporidae” OR “Drosophila” OR “primate” OR “monkey”
OR “Macaca” OR “macaque” OR “ape” OR “rhesus” OR “chimpanzee” OR
“bonobo” OR “gorilla” OR “Pan” OR “Orang Utan” OR “Pongo” OR “gibbon”
OR “Hylobates” OR “Colobus” OR “Baboon” OR “Papio” OR “Mandrillus” OR
“Mandrill” OR “Cebus” OR “Cebuella” OR “Brachyteles” OR “Loris” OR “Nycticebus” OR “Lemur” OR “dog” OR “Canis” OR “cat” OR “Felis.”
We found 33 published papers using nhps as models and randomly selected
seven, using the same randomizing tool. We found over 1,000 published papers
using other animals as models and proceeded, as above, to randomly select 18
papers for the citation analysis. We recorded the number of citations each paper received from subsequent animal research papers and subsequent human
research papers. We similarly analyzed the aim of the citing paper (whether
it was focused on the same disorder or another), in both animal and human
papers.
Using Fisher’s exact test (http://www.kisnet.or.jp/nappa/software/star-e/
freq/1x2.htm), we investigated whether there was a significant difference between the number of citations of the target animal articles in human research
papers and in animal research papers. We also verified whether there was a
significant difference between the number of citations in subsequent articles
addressing the same disorder and subsequent articles addressing different topics. Differences were considered statistically significant if p<0.05.
3

Results

Regarding our adhd sample, the 25 original animal studies were cited 660
times. As shown in Figure 16.1, animal studies were mainly cited in other animal research papers (315), of which 82 focused on adhd and 233 focused on
different subjects. The sample resulted in 69 citations in human research papers, of which 30 focused on adhd and 39 focused on different subjects. The
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39
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Citations by Human Papers

Citations of animal papers focused on adhd.

remaining 345 citations were in review articles (198) or papers describing different methods, such as in silico or in vitro (147).
The columns represent the number of citations of the 25 target papers in
animal research papers (blue) and human research papers (orange). The t otal
number (left), as well as the number of citations in papers studying adhd
(middle) and other subjects (right) are presented. Fisher’s exact test p-values
are also presented for each comparison made (n.s.= non-significant).
The number of citations in animal research papers was far greater than the
number of citations in human research papers (p<0.0001). The number of citations in animal research papers focused on adhd was lower than the number
of citations in animal research papers focused on other subjects (p<0.0001).
The difference between the number of citations in human research papers on
adhd and human research papers focused on other subjects was not statistically significant (p=0.3355).
Seven of the target papers reported nhp studies. These papers received 274
citations, 94 of which were in subsequent animal research papers and 48 were
in human research papers. The remaining 138 citations were in review papers
(96) or papers describing different methods, such as in silico or in vitro (42). The
difference between citations in animal research papers and human research
papers was statistically significant (p=0.0001). Of the 94 citations in subsequent
animal papers, 21 were in papers focused on adhd, and 73 were in papers focused
on other issues. This difference was also statistically significant (p<0.0001).
Of the 48 citations in human research papers, 15 were in papers focused on
adhd, and 33 were in papers describing other disorders. Fisher’s exact test
showed that in the case of nhps there was a statistically significant difference
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between the number of citations in papers on adhd and papers focused on
other subjects (p=0.0132).
Regarding the mdd sample, the 25 target animal studies were cited 631
times. As shown in Figure 16.2, animal studies were mainly cited in other
animal research papers (353), of which 127 focused on mdd, and 226 focused
on different subjects. The sample received 51 citations in human research papers, of which 19 focused on mdd, and 32 focused on different subjects. The
remaining 227 citations were in review articles (163) or papers describing
different m
 ethods, such as in silico or in vitro (64).
The columns represent the number of citations in animal research papers
(blue) and in human research papers (orange) of the 25 cited papers. The total number (left), as well as the number of citations in papers studying mdd
(middle) and other subjects (right) are presented. Fisher’s exact test p-values
are also presented for each comparison made.
The number of citations in animal research papers was substantially greater
than the number of citations in human research papers (Fisher’s exact test,
p<0.0001). The number of citations in animal research papers focused on
mdd was lower than the number of citations in papers focused other subjects
(p<0.0001). The difference between the number of citations in human research
papers focused on mdd and papers focused on other subjects was not statistically significant (p=0.0919).
The seven papers reporting on nhp studies received 227 citations, 97 of
which were in subsequent animal research papers, and 19 were in human research papers. This difference was statically significant (p=0.001). Of the 97
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c itations in subsequent animal papers, 13 were in papers on mdd, and 84 were
in papers focused on other issues. This difference was statistically significant
(p<0.0001). Of the 19 citations in human medical papers, six were in papers on
mdd, and 13 were in papers focused on other subjects. This difference was not
statistically significant (p=0.1670).
4

Discussion

Our results suggest that animal data is mainly used by subsequent animal papers. Another trend that emerged is that papers citing animal research (whether they focus on human medical research or not) focus on disorders that differ
from the one targeted in the animal study cited. This trend is stronger in papers
focused on animal research.
The tendency for animal research to be cited more in subsequent animal
research has been previously described (e.g., Carvalho et al., 2016). This finding
contradicts the previously stated assumption that citations in human-focused
papers should constitute a substantial proportion of the total number of citations. Clearly, biomedical research focused on animal models does not seem
to be considered important by, or particularly visible to, the human medical
research community.
Our results also indicate that papers citing data collected from animal models do not necessarily target the disorder described in the animal paper. This
difference appears to be more significant in animal research papers citing
other animal research papers, than in human research papers that cite a nimal
research. This contradicts the second assumption we tested: that citations
should be made mainly by studies focused on the same disorder. This finding
reinforces the concern that animal-based research is failing to shape meaningful healthcare advances for humans.
It can be argued that if the same animal model is used for different disorders, it may contribute more to medical research than predicted by the second
assumption. For example, dat knock-out mice comprise a common model for
adhd but are also used to model Parkinson or schizophrenia (Gainetdinov,
2008). Nevertheless, the total citation frequency in human research papers
is still very low, regardless of the paper’s area of focus (Carvalho et al., 2016;
Knight, 2007; Long, Huang and Ho, 2014).
The fact that animal strains are used to model several disorders may help
explain the intriguing tendency for animal research papers to be cited more
often in papers addressing non-related subjects than in papers focused on the
same disorder. This tendency was also apparent in human-based papers that
cited animal-based papers focused on mdd. This may have occurred because
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there are 6–7 times more papers focused on mdd than on adhd, which may
mean that the 25 papers on mdd were not a representative sample of mdd research. If this phenomenon was to recur with a larger sample, one could argue
that this is due to the same animal strain being used for different purposes, as
previously mentioned. If the strains used in mdd research are commonly used
to model a greater number of disorders than strains used in adhd research, it
would be more probable that human studies focused on unrelated disorders
cite studies in these strains. We did not verify this, and it should be explored in
future studies.
Our data shows that even though the difference between the total frequency of citations by human papers focused on adhd and paper focused on other
subjects was not statistically significant, there was a bias regarding papers describing nhp models of adhd. A close examination of the data allowed us to
conclude that this bias was due to one paper, cited 18 times in human research
papers, 17 of which focused on disorders other than adhd. This particular paper described the behavioral changes caused by bicuculline microinjections
in external globus pallidus, a brain structure involved in pathogenesis of adhd
but also in Tourette’s syndrome. Most of the 18 citations this paper received in
human papers were actually from papers related to Tourette’s syndrome. If we
discard this outlier, the data on nhp follows the same pattern as other adhd
papers.
Since our two assumptions have been challenged, we must discuss their
causes and implications. One possible explanation for these results is that
animal models only attempt to model specific symptoms or traits of complex human disorders. This oversimplification may lead to results that are
non-applicable or of minimal use for human medicine. Another possible explanation is that funding is more easily attached to studies that claim to have
the potential to advance human health. This may lead animal researchers to
overestimate the applicability of their projects. A further possible explanation
is that communication and sharing of ideas between clinical and preclinical
research is insufficient. Moreover, previous studies have shown that clinical
and preclinical trials can occur simultaneously (Pound et al., 2004), which
emphasizes this lack of communication. Although it is difficult to define an
optimum communication level, this issue must be raised in both communities in order to maximize efficiency in scientific research as well as the promotion of animal welfare. An additional possibility is that a substantial amount
of animal research is needed in order to achieve a critical mass that can lead
to useful breakthroughs in human health. This is a theoretical possibility that
is difficult to measure and properly test. However, even if proven correct, the
financial and ethical implications of this assumption should be considered.
Other methods may prove to be more efficient or ethically acceptable, and this
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comparison could lead to a reevaluation of funding priorities. Finally, a conceivable possibility is that animal models are not suitable for biomedical research into complex human disorders. It may be possible that the uniqueness
of some human disorders is just not feasibly simulated in non-human animals.
If our last suggested explanation is indeed correct, the implications must
be considered. The funding currently allocated to these animal-based studies
should still be available for science. While most of it would likely be redirected
to other models of these disorders, some of it could be assigned either to other
basic research fields or to the care of surplus animals.
Regardless of the possible explanations, our results indicate that animalbased research is failing to reach the human medical community, at least in
the case of mental disorders, such as the ones we evaluated. This means that
considerable financial investment and considerable suffering inflicted on the
animals used for this purpose did not translate into direct medical advances. It
would be interesting to survey the practitioners working with mental disorders
to assess if this is due to lack of awareness of animal-based findings, or if they
consider animal-based data to be inadequate or lacking in relevance.
In conclusion, our analysis suggests that most animal-based research, at
least in the case of these mental disorders, is not currently being utilized by
human-based researchers. Regardless of the reasons for this, the profound financial and ethical implications should lead to a reevaluation of the current
research paradigm, which is heavily reliant on invasive animal use.
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